MedPath

Endoscopic papillary large balloon dilation with or without small endoscopic sphincterotomy do not preserve sphincter of Oddi function after large bile duct stones management: a prospective randomized study

Not Applicable
Completed
Conditions
Diseases of the digestive system
Registration Number
KCT0000877
Lead Sponsor
Konkuk University Medical Center
Brief Summary

One week after EPLBD alone and EST with EPLBD, the basal pressure of SO dropped from 30.4 (8.2) to 6.4 (8.4) (p < .001) and 29.5 (18.9) to 2.9 (3.6) mmHg (p < .001), respectively. SO function was not recovered at 1 year, as the manometric measures were similar to those taken at the 1-week time point in both groups. Similar outcomes were obtained in patients with EPLBD alone compared with those with EST and EPLBD, including initial stone clearance rate (95.2% vs. 97.7%, p = .612), frequency of mechanical lithotripsy (21.4% vs. 13.6%), and overall complications (11.9% vs. 13.6%, p = 1.0) including post-procedure pancreatitis rate (7.1% vs. 11.4%, p = .714). During an overall median follow-up of 17.8 months, the bile duct stone recurrence rate was 16.7% in EPLBD alone patients and 15.9% in EST with EPLBD patients (p = .924).

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients who have large bile duct stones (stone diameter > 12mm) and do not perfom a previous ednoscopic sphincterotomy

Exclusion Criteria

1. coagulopathy (> 1.5 INR)
2. pregnant
3. Previous EST
4. Anticoagulants or antiplateate agents user
5. Stone diameter more than 50mm
6. Failure a selective bile duct cannulation
9. less than 18 years or more than 90 years

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of sphincter of Oddi funtion after two procedures;Success rate of common bile duct stones
Secondary Outcome Measures
NameTimeMethod
Complications rate related with procedures;Mechanical lithotripsy use
© Copyright 2025. All Rights Reserved by MedPath